<div id=toc></div>

# Table of Contents

- [q-bio.BM](#q-bio.BM) [Total: 1]
- [q-bio.CB](#q-bio.CB) [Total: 1]
- [cs.LG](#cs.LG) [Total: 1]


<div id='q-bio.BM'></div>

# q-bio.BM [[Back]](#toc)

### [1] [ODesign: A World Model for Biomolecular Interaction Design](https://arxiv.org/abs/2510.22304)
*Odin Zhang,Xujun Zhang,Haitao Lin,Cheng Tan,Qinghan Wang,Yuanle Mo,Qiantai Feng,Gang Du,Yuntao Yu,Zichang Jin,Ziyi You,Peicong Lin,Yijie Zhang,Yuyang Tao,Shicheng Chen,Jack Xiaoyu Chen,Chenqing Hua,Weibo Zhao,Runze Ma,Yunpeng Xia,Kejun Ying,Jun Li,Yundian Zeng,Lijun Lang,Peichen Pan,Hanqun Cao,Zihao Song,Bo Qiang,Jiaqi Wang,Pengfei Ji,Lei Bai,Jian Zhang,Chang-yu Hsieh,Pheng Ann Heng,Siqi Sun,Tingjun Hou,Shuangjia Zheng*

Main category: q-bio.BM

TL;DR: ODesign是一种全原子生成世界模型，用于所有生物分子相互作用设计，提供对相互作用细节的精细控制，并在蛋白质、核酸和小分子设计中表现出卓越的性能。


<details>
  <summary>Details</summary>
Motivation: 生物分子相互作用是几乎所有生物过程的基础，但目前大多数生成AI模型局限于特定分子类型，缺乏对相互作用细节的精细控制。

Method: 提出了ODesign，一种全原子生成世界模型，能够指定任意靶标上的表位并生成多样化的结合伴侣。

Result: 在蛋白质模态的多个基准测试中表现出优于特定模态基线的可控性和性能，并能扩展到核酸和小分子设计。

Conclusion: ODesign通过统一多模态生物分子相互作用，实现了通用分子世界模型的目标，为可编程设计提供了可能。

Abstract: Biomolecular interactions underpin almost all biological processes, and their
rational design is central to programming new biological functions. Generative
AI models have emerged as powerful tools for molecular design, yet most remain
specialized for individual molecular types and lack fine-grained control over
interaction details. Here we present ODesign, an all-atom generative world
model for all-to-all biomolecular interaction design. ODesign allows scientists
to specify epitopes on arbitrary targets and generate diverse classes of
binding partners with fine-grained control. Across entity-, token-, and
atom-level benchmarks in the protein modality, ODesign demonstrates superior
controllability and performance to modality-specific baselines. Extending
beyond proteins, it generalizes to nucleic acid and small-molecule design,
enabling interaction types such as protein-binding RNA/DNA and RNA/DNA-binding
ligands that were previously inaccessible. By unifying multimodal biomolecular
interactions within a single generative framework, ODesign moves toward a
general-purpose molecular world model capable of programmable design. ODesign
is available at https://odesign.lglab.ac.cn ,

</details>


<div id='q-bio.CB'></div>

# q-bio.CB [[Back]](#toc)

### [2] [Beyond Autophagy: VPS39 Deficiency Triggers Migrasome-Driven Stress Adaptation Revealed by Super-Resolution Imaging](https://arxiv.org/abs/2510.22179)
*Xuelei Pang,Weiyun Sun,Ning Jing,Wenwen Gong,Cuifang Kuang,Xu Liu,Hanbing Li,Yu-Hui Zhang,Yubing Han*

Main category: q-bio.CB

TL;DR: VPS39是关键分子开关，协调自噬和迁移体的形成。VPS39缺失不仅损害自噬流，还通过激活RhoA/Rac1 GTPases促进迁移体形成，迁移体可作为受损线粒体的替代清除途径。


<details>
  <summary>Details</summary>
Motivation: 探索自噬与迁移体之间的补偿性关系及其分子机制。

Method: 通过基因敲除VPS39，结合超分辨显微镜观察迁移体功能。

Result: 发现VPS39是调节自噬与迁移体形成的分子开关，迁移体在自噬受损时清除受损线粒体。

Conclusion: 研究揭示了自噬-迁移体轴的存在，为神经退行性疾病治疗提供新策略。

Abstract: Autophagy and migrasome formation constitute critical cellular mechanisms for
maintaining cellular homeostasis, however, their potential compensatory
interplay remains poorly understood. In this study, we identify VPS39, a core
component of the HOPS complex, as a molecular switch coordinating these
processes. Genetic ablation of VPS39 not only impairs autophagic flux but also
triggers cell migration through RhoA/Rac1 GTPases upregulation, consequently
facilitating migrasome formation. Using super-resolution microscopy, we further
demonstrate that migrasomes serve as an alternative disposal route for damaged
mitochondria during VPS39-induced autophagy impairment, revealing a novel
stress adaptation mechanism. Our work establishes a previously unrecognized
autophagy-migrasome axis and provides direct visual evidence of organelle
quality control via migrasomal extrusion. These findings position
VPS39-regulated pathway switching as a potential therapeutic strategy for
neurodegenerative diseases characterized by autophagy dysfunction.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [3] [Symbolic Neural Generation with Applications to Lead Discovery in Drug Design](https://arxiv.org/abs/2510.23379)
*Ashwin Srinivasan,A Baskar,Tirtharaj Dash,Michael Bain,Sanjay Kumar Dey,Mainak Banerjee*

Main category: cs.LG

TL;DR: 本文探讨了一种结合符号学习和神经推理的混合神经符号模型（SNG），用于生成符合形式正确性标准的数据。SNG通过符号学习者分析少量实例的逻辑规范，约束神经生成器的输出，确保实例符合规范。实验表明，SNG在药物设计中表现优异，生成的分子的结合亲和力与领先临床候选药物相当。


<details>
  <summary>Details</summary>
Motivation: 研究动机在于探索一种结合符号和神经方法的混合模型，以解决传统方法在生成符合形式正确性数据时的局限性，尤其是在数据量较少的场景下。

Method: 方法包括使用符号学习者分析逻辑规范，并将其作为约束条件输入神经生成器，生成符合规范的实例。此外，还引入了基于部分有序集的语义和概率扩展。

Result: 在药物设计实验中，SNG在基准问题和探索性问题中均表现出色，生成的分子的结合亲和力与领先临床候选药物相当，且专家认为符号规范可用作初步筛选工具。

Conclusion: 结论是SNG结合了符号和神经方法的优点，能够有效生成符合形式正确性标准的数据，尤其在数据稀疏和探索性问题中表现优异。

Abstract: We investigate a relatively underexplored class of hybrid neurosymbolic
models integrating symbolic learning with neural reasoning to construct data
generators meeting formal correctness criteria. In \textit{Symbolic Neural
Generators} (SNGs), symbolic learners examine logical specifications of
feasible data from a small set of instances -- sometimes just one. Each
specification in turn constrains the conditional information supplied to a
neural-based generator, which rejects any instance violating the symbolic
specification. Like other neurosymbolic approaches, SNG exploits the
complementary strengths of symbolic and neural methods. The outcome of an SNG
is a triple $(H, X, W)$, where $H$ is a symbolic description of feasible
instances constructed from data, $X$ a set of generated new instances that
satisfy the description, and $W$ an associated weight. We introduce a semantics
for such systems, based on the construction of appropriate \textit{base} and
\textit{fibre} partially-ordered sets combined into an overall partial order,
and outline a probabilistic extension relevant to practical applications. In
this extension, SNGs result from searching over a weighted partial ordering. We
implement an SNG combining a restricted form of Inductive Logic Programming
(ILP) with a large language model (LLM) and evaluate it on early-stage drug
design. Our main interest is the description and the set of potential inhibitor
molecules generated by the SNG. On benchmark problems -- where drug targets are
well understood -- SNG performance is statistically comparable to
state-of-the-art methods. On exploratory problems with poorly understood
targets, generated molecules exhibit binding affinities on par with leading
clinical candidates. Experts further find the symbolic specifications useful as
preliminary filters, with several generated molecules identified as viable for
synthesis and wet-lab testing.

</details>
